Tsutsumida Arata, Furukawa Hiroshi, Yamamoto Yuhei, Sugihara Tsuneki
Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Hokkaido University, Kita 15, Sapporo 060-8638, Japan.
Int J Clin Oncol. 2005 Oct;10(5):311-7. doi: 10.1007/s10147-005-0522-9.
The incidence of cutaneous malignant melanoma has been rising in Japan. With education, recent advances in accurate diagnosis and establishment of the concept, more lesions are being diagnosed as early melanomas, for which there is a high cure rate. However, many patients will still present with thicker lesions or nodal involvement, which carries a significantly worse prognosis. Recently there have been advances in the management and treatment of cutaneous melanoma. This article reviews the clinical evidence behind the current treatment recommendations for primary and recurrent cutaneous melanoma in Japan.
在日本,皮肤恶性黑色素瘤的发病率一直在上升。随着教育的普及、准确诊断方面的最新进展以及概念的确立,越来越多的病变被诊断为早期黑色素瘤,其治愈率很高。然而,仍有许多患者会出现较厚的病变或淋巴结受累,这会带来明显更差的预后。最近,皮肤黑色素瘤的管理和治疗取得了进展。本文回顾了日本原发性和复发性皮肤黑色素瘤当前治疗建议背后的临床证据。